Mann, M.J., Dzau, V.J., Therapeutic applications of transcription factor decoy oligonucleotides (2000) J. Clin. Invest, 106, pp. 1071-1075
Yang, H., Wang, H., Tracey, K.J., HMG-1 rediscovered as a cytokine (2001) Shock, 15, pp. 247-253
Musumeci, D. Therapeutic agents comprising synthetic double-stranded nucleic acid with a bent shape structure for the treatment of HMGB1-related pathologies. PCT Int. Appl. 2006, WO2006002971UR - http://www.scopus.com/inward/record.url?eid=2-s2.0-36849050680&partnerID=40&md5=23077bcec77cac595f8a785e81c7920c
(1989) Oligonucleotides: Antisense Inhibitors of Gene Expression, Cohen, , J. S. Ed, CRC Press, Boca Raton, FL
Mann, M. J., Dzau, V. J., Therapeutic applications of transcription factor decoy oligonucleotides (2000) J. Clin. Invest, 106, pp. 1071-1075
ODN-based drugs for targeting of extracellular proteins
Petraglia F, Singh AA, Carafa V, Nebbioso A, Conte M, Scisciola L, Valente S, Baldi A, Mandoli A, Petrizzi VB, Ingenito C, De Falco S, Cicatiello V, Apicella I, Janssen-megens EM, Kim B, Yi G, Logie C, Heath S, Ruvo M, Wierenga ATJ, Flicek P, Yaspo ML, Della Valle V, Bernard O, Tomassi S, Novellino E, Feoli A, Sbardella G, Gut I, Vellenga E, Stunnenberg HG, Mai A, Martens JHA, Altucci L * Combined HAT/EZH2 modulation leads to cancer-selective cell death(288 views) Oncotarget (ISSN: 1949-2553electronic, 1949-2553linking), 2018 May 22; 9(39): 25630-25646. Impact Factor:5.008 ViewExport to BibTeXExport to EndNote